Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16153463 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall
Conditions: Soft Tissue Sarcoma;   Non Metastatic Disease
Interventions: Drug: doxorubicin , ifosfamide;   Drug: doxorubicin, ifosfamide

Indicates status has not been verified in more than two years